These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29355992)

  • 1. Antithrombotic therapy in peripheral artery disease: A review of the EUCLID trial results and current ongoing trials.
    Ward R; Long C; Patel MR; Jones WS
    Clin Cardiol; 2018 Jan; 41(1):137-143. PubMed ID: 29355992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
    Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
    Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial.
    Berger JS; Katona BG; Jones WS; Patel MR; Norgren L; Baumgartner I; Blomster J; Mahaffey KW; Held P; Millegård M; Heizer G; Reist C; Fowkes FG; Hiatt WR
    Am Heart J; 2016 May; 175():86-93. PubMed ID: 27179727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic treatment in peripheral artery disease.
    Olinic DM; Tataru DA; Homorodean C; Spinu M; Olinic M
    Vasa; 2018 Feb; 47(2):99-108. PubMed ID: 29160765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease.
    Jones WS; Baumgartner I; Hiatt WR; Heizer G; Conte MS; White CJ; Berger JS; Held P; Katona BG; Mahaffey KW; Norgren L; Blomster J; Millegård M; Reist C; Patel MR; Fowkes FG;
    Circulation; 2017 Jan; 135(3):241-250. PubMed ID: 27840336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic strategies for patients with coronary and lower extremity peripheral artery diseases: a narrative review.
    De Luca L; Bonaca MP; Magnani G
    Expert Rev Cardiovasc Ther; 2020 Dec; 18(12):881-889. PubMed ID: 33021875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke in Patients With Peripheral Artery Disease.
    Kolls BJ; Sapp S; Rockhold FW; Jordan JD; Dombrowski KE; Fowkes FGR; Mahaffey KW; Berger JS; Katona BG; Blomster JI; Norgren L; Abramson BL; Leiva-Pons JL; Prieto JC; Sokurenko G; Hiatt WR; Jones WS; Patel MR
    Stroke; 2019 Jun; 50(6):1356-1363. PubMed ID: 31092165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial.
    Gutierrez JA; Mulder H; Jones WS; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Katona BG; Mahaffey KW; Norgren L; Hiatt WR; Patel MR
    JAMA Netw Open; 2018 Nov; 1(7):e185239. PubMed ID: 30646395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial.
    Low Wang CC; Blomster JI; Heizer G; Berger JS; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Lopes RD; Olin JW; Rockhold FW; Mahaffey KW; Patel MR; Hiatt WR;
    J Am Coll Cardiol; 2018 Dec; 72(25):3274-3284. PubMed ID: 30573030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery Disease.
    Szarek M; Hess C; Patel MR; Jones WS; Berger JS; Baumgartner I; Katona B; Mahaffey KW; Norgren L; Blomster J; Rockhold FW; Hsia J; Fowkes FGR; Bonaca MP
    J Am Heart Assoc; 2022 Jun; 11(11):e025504. PubMed ID: 35621222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is aspirin still the drug of choice for management of patients with peripheral arterial disease?
    Poredos P; Jezovnik MK
    Vasa; 2013 Mar; 42(2):88-95. PubMed ID: 23485835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial.
    Olivier CB; Mulder H; Hiatt WR; Jones WS; Fowkes FGR; Rockhold FW; Berger JS; Baumgartner I; Held P; Katona BG; Norgren L; Blomster J; Patel MR; Mahaffey KW
    JAMA Cardiol; 2019 Jan; 4(1):7-15. PubMed ID: 30540355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotics in stable peripheral artery disease.
    Kaplovitch E; Rannelli L; Anand SS
    Vasc Med; 2019 Apr; 24(2):132-140. PubMed ID: 30799766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial.
    Norgren L; North R; Baumgartner I; Berger JS; Blomster JI; Hiatt WR; Jones WS; Katona BG; Mahaffey KW; Mulder H; Patel MR; Rockhold FW; Fowkes FGR
    Vasc Med; 2022 Feb; 27(1):21-29. PubMed ID: 34516308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic Therapy in Lower Extremity Artery Disease.
    Vrsalovic M; Aboyans V
    Curr Vasc Pharmacol; 2020; 18(3):215-222. PubMed ID: 30727898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial.
    Norgren L; Patel MR; Hiatt WR; Wojdyla DM; Fowkes FGR; Baumgartner I; Mahaffey KW; Berger JS; Jones WS; Katona BG; Held P; Blomster JI; Rockhold FW; Björck M;
    Eur J Vasc Endovasc Surg; 2018 Jan; 55(1):109-117. PubMed ID: 29273390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New opportunities to optimize antithrombotic therapy for secondary stroke prevention.
    Kim AS; Easton JD
    Int J Stroke; 2019 Apr; 14(3):220-222. PubMed ID: 30722755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.
    Hiatt WR; Fowkes FG; Heizer G; Berger JS; Baumgartner I; Held P; Katona BG; Mahaffey KW; Norgren L; Jones WS; Blomster J; Millegård M; Reist C; Patel MR;
    N Engl J Med; 2017 Jan; 376(1):32-40. PubMed ID: 27959717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tackling Elevated Risk in PAD: Focus on Antithrombotic and Lipid Therapy for PAD.
    Govsyeyev N; Nehler MR; Hiatt WR; Bonaca MP
    Curr Cardiol Rep; 2020 Jan; 22(3):13. PubMed ID: 31997026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease.
    Di Minno G; Spadarella G; Cafaro G; Petitto M; Lupoli R; Di Minno A; de Gaetano G; Tremoli E
    Ann Med; 2014 Nov; 46(7):475-89. PubMed ID: 25045928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.